112 related articles for article (PubMed ID: 34242818)
1. Matrix metalloprotease-14 is a target enzyme for detecting peritoneal metastasis in gastric cancer.
Ogawa S; Kubo H; Murayama Y; Kubota T; Yubakami M; Matsumoto T; Ohashi T; Okamoto K; Kuriki Y; Hanaoka K; Urano Y; Otsuji E
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102420. PubMed ID: 34242818
[TBL] [Abstract][Full Text] [Related]
2. β-Galactosidase is a target enzyme for detecting peritoneal metastasis of gastric cancer.
Kubo H; Murayama Y; Ogawa S; Matsumoto T; Yubakami M; Ohashi T; Kubota T; Okamoto K; Kamiya M; Urano Y; Otsuji E
Sci Rep; 2021 May; 11(1):10664. PubMed ID: 34021168
[TBL] [Abstract][Full Text] [Related]
3. PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN.
Xiong J; Li Z; Zhang Y; Li D; Zhang G; Luo X; Jie Z; Liu Y; Cao Y; Le Z; Tan S; Zou W; Gong P; Qiu L; Li Y; Wang H; Chen H
Oncol Rep; 2016 Oct; 36(4):1819-28. PubMed ID: 27572739
[TBL] [Abstract][Full Text] [Related]
4. Soluble PD-L1 Expression in Circulation as a Predictive Marker for Recurrence and Prognosis in Gastric Cancer: Direct Comparison of the Clinical Burden Between Tissue and Serum PD-L1 Expression.
Shigemori T; Toiyama Y; Okugawa Y; Yamamoto A; Yin C; Narumi A; Ichikawa T; Ide S; Shimura T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Araki T; Kusunoki M
Ann Surg Oncol; 2019 Mar; 26(3):876-883. PubMed ID: 30565045
[TBL] [Abstract][Full Text] [Related]
5. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis.
Okugawa Y; Toiyama Y; Hur K; Toden S; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Kusunoki M; Boland CR; Goel A
Carcinogenesis; 2014 Dec; 35(12):2731-9. PubMed ID: 25280565
[TBL] [Abstract][Full Text] [Related]
6. High serum MMP-14 predicts worse survival in gastric cancer.
Kasurinen A; Tervahartiala T; Laitinen A; Kokkola A; Sorsa T; Böckelman C; Haglund C
PLoS One; 2018; 13(12):e0208800. PubMed ID: 30532247
[TBL] [Abstract][Full Text] [Related]
7. Combined features based on MT1-MMP expression, CD11b + immunocytes density and LNR predict clinical outcomes of gastric cancer.
Peng CW; Wang LW; Fang M; Yang GF; Li Y; Pang DW
J Transl Med; 2013 Jun; 11():153. PubMed ID: 23787075
[TBL] [Abstract][Full Text] [Related]
8. Expression of MMP-7 and MT1-MMP in peritoneal dissemination of gastric cancer.
Yoshikawa T; Yanoma S; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Miyagi Y; Morinaga S; Noguchi Y; Yamamoto Y
Hepatogastroenterology; 2006; 53(72):964-7. PubMed ID: 17153464
[TBL] [Abstract][Full Text] [Related]
9. Establishment of Peritoneal and Hepatic Metastasis Mouse Xenograft Models Using Gastric Cancer Cell Lines.
Miwa T; Kanda M; Umeda S; Tanaka H; Shimizu D; Tanaka C; Kobayashi D; Hayashi M; Yamada S; Nakayama G; Koike M; Kodera Y
In Vivo; 2019; 33(6):1785-1792. PubMed ID: 31662503
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
Liu Y; Liu H; Luo X; Deng J; Pan Y; Liang H
Tumour Biol; 2015 Jun; 36(6):4377-86. PubMed ID: 25627005
[TBL] [Abstract][Full Text] [Related]
11. RABEX-5 overexpression in gastric cancer is correlated with elevated MMP-9 level.
Kang L; Hao X; Tang Y; Wei X; Gong Y
Am J Transl Res; 2016; 8(5):2365-74. PubMed ID: 27347344
[TBL] [Abstract][Full Text] [Related]
12. Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis.
Kimura A; Ogata K; Altan B; Yokobori T; Mochiki E; Yanai M; Kogure N; Yanoma T; Suzuki M; Bai T; Kuwano H
World J Gastroenterol; 2017 Nov; 23(42):7541-7550. PubMed ID: 29204054
[TBL] [Abstract][Full Text] [Related]
13. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Zhang S; Li L; Lin JY; Lin H
World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
[TBL] [Abstract][Full Text] [Related]
14. Increased MT2-MMP expression in gastric cancer patients is associated with poor prognosis.
Xu X; Chen L; Xu B; Xie Q; Sun M; Deng X; Wu C; Jiang J
Int J Clin Exp Pathol; 2015; 8(2):1985-90. PubMed ID: 25973093
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer.
Kushlinskii NE; Gershtein ES; Ivannikov AA; Davydov MM; Chang VL; Ognerubov NA; Stilidi IS
Bull Exp Biol Med; 2019 Jan; 166(3):373-376. PubMed ID: 30627896
[TBL] [Abstract][Full Text] [Related]
16. Serum Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) mRNA Protected by Exosomes as a Potential Biomarker for Gastric Cancer.
Dong Z; Sun X; Xu J; Han X; Xing Z; Wang D; Ge J; Meng L; Xu X
Med Sci Monit; 2019 Oct; 25():7770-7783. PubMed ID: 31619663
[TBL] [Abstract][Full Text] [Related]
17. Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer.
Kanda M; Shimizu D; Tanaka H; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Niwa Y; Yamada S; Fujii T; Sugimoto H; Murotani K; Fujiwara M; Kodera Y
Ann Surg; 2018 Mar; 267(3):495-503. PubMed ID: 28026832
[TBL] [Abstract][Full Text] [Related]
18. Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer.
Elnemr A; Yonemura Y; Bandou E; Kinoshita K; Kawamura T; Takahashi S; Tochiori S; Endou Y; Sasaki T
Gastric Cancer; 2003; 6(1):30-8. PubMed ID: 12673424
[TBL] [Abstract][Full Text] [Related]
19. The Association of HOTAIR with the Diagnosis and Prognosis of Gastric Cancer and Its Effect on the Proliferation of Gastric Cancer Cells.
Xu Z; Chen H; Yang B; Liu X; Zhou X; Kong H
Can J Gastroenterol Hepatol; 2019; 2019():3076345. PubMed ID: 31281803
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of Basing Treatment Strategy on the Results of Photodynamic Diagnosis in Advanced Gastric Cancer.
Ushimaru Y; Fujiwara Y; Kishi K; Sugimura K; Omori T; Moon JH; Yanagimoto Y; Ohue M; Yasui M; Takahashi H; Kobayashi S; Akita H; Miyoshi N; Tomokuni A; Sakon M; Yano M
Ann Surg Oncol; 2017 Apr; 24(4):983-989. PubMed ID: 27822632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
